Kadcyla In pAtients With bRAin Metastasis

Clinical trial NCT03203616 · WITHDRAWN

Trial details

NCT number: NCT03203616
Sponsor: Jules Bordet Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic HER2-positive Breast Cancer With Brain Metastasis

Start date: 2018-02-23
Primary completion: 2018-08-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.